Michael Burgess actually said...

Reauthorizing improved generic and biosimilar user fee programs will lead to timelier approvals and lower drug costs. It's that simple.

Context

Burgess emphasizes the importance of user fee reauthorization for drug cost reduction.

03/01/2017

https://congress.gov...

More Michael Burgess Quotes

View All Michael Burgess Quotes